Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
Authors:
- K.Scott MillerKMK.Scott Miller
- Margaret B. KinsellaMKMargaret B. Kinsella
- Edwin A. SmithESEdwin A. Smith
- Stephen I. SchabelSSStephen I. Schabel
- 1 May 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (5) , 470-476
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- SPONTANEOUS PRODUCTION OF FIBRONECTIN BY ALVEOLAR MACROPHAGES IN PATIENTS WITH SCLERODERMAArthritis & Rheumatism, 1989
- A Clinical, Radiographic, and Physiologic Scoring System for the Longitudinal Assessment of Patients with Idiopathic Pulmonary FibrosisAmerican Review of Respiratory Disease, 1986
- Evidence for Chronic Inflammation as a Component of the Interstitial Lung Disease Associated with Progressive Systemic SclerosisAmerican Review of Respiratory Disease, 1985
- Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosisThe American Journal of Medicine, 1984
- Lung Involvement in SclerodermaChest, 1984
- Safety of Fiberoptic Bronchoalveolar Lavage in Evaluation of Interstitial Lung DiseaseChest, 1981
- Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.Thorax, 1980
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.Journal of Clinical Investigation, 1977
- Survival with Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1971